Timothy K. Huyck

发表

Thromboembolic and bleeding complications in acute leukemia

H. Kwaan, Timothy K. Huyck, 2010, Expert review of hematology.

Single-arm, phase 2 study of regorafenib plus nivolumab in patients with mismatch repair-proficient (pMMR)/microsatellite stable (MSS) colorectal cancer (CRC).

N. Sharma, M. Fakih, J. Bendell, 2021 .

Drugs for Primary Brain Tumors: An Update

J. Raizer, Lauren Nye, Timothy K. Huyck, 2014 .

Neoadjuvant Use of Sunitinib in Locally Advanced GIST with Intolerance to Imatinib

J. Wayne, M. Agulnik, Timothy K. Huyck, 2012, Chemotherapy.

Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).

T. Bekaii-Saab, B. El-Rayes, B. O'Neil, 2019, European journal of cancer.

Regorafenib plus nivolumab in patients with mismatch repair-proficient/microsatellite stable metastatic colorectal cancer: a single-arm, open-label, multicentre phase 2 study.

B. Ploeger, N. Sharma, M. Fakih, 2023, EClinicalMedicine.

Lorazepam, diphenhydramine, and haloperidol transdermal gel for rescue from chemotherapy-induced nausea/vomiting: results of two pilot trials.

A. Bardia, C. Loprinzi, P. Silberstein, 2008, The journal of supportive oncology.

Eribulin mesylate

P. Kirkpatrick, F. Manuguid, Timothy K. Huyck, 2021, Nature Reviews Drug Discovery.

Diagnostic and treatment considerations when newly diagnosed breast cancer coincides with pregnancy: a case report and review of literature.

W. Gradishar, Lauren Nye, Timothy K. Huyck, 2012, Journal of the National Comprehensive Cancer Network : JNCCN.

Molecular Therapies in Thyroid Cancer

M. Agulnik, Timothy K. Huyck, 2010, Pharmaceuticals.

Phase II randomised, double-blind study of mFOLFIRINOX plus ramucirumab versus mFOLFIRINOX plus placebo in advanced pancreatic cancer patients (HCRN GI14-198).

T. Bekaii-Saab, B. El-Rayes, T. Khair, 2023, European journal of cancer.